| 1 | [SID7972728] | Active | AbsAC40_uM | 0.516 | In vivo-based yeast HTS counterscreen to detect compounds rescuing yeast growth/survival of Saccharomyces cerevisiae SKN7-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-02_Inhibitor_Dose_CherryPick_Activity [AID624258, Type: confirmatory] | Skn7p [Saccharomyces cerevisiae] [gi:458922] |  View X | Row No. | 1 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | AbsAC40_uM | 0.516 [uM] | | BioAssay | In vivo-based yeast HTS counterscreen to detect compounds rescuing yeast growth/survival of Saccharomyces cerevisiae SKN7-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-02_Inhibitor_Dose_CherryPick_Activity | | AID | 624258 | | BioAssay type | confirmatory | | Target | Skn7p [Saccharomyces cerevisiae] [gi:458922] | | PubMed | | | Data Table |  |
|
| 2 | [SID7972728] | Active | AbsAC1000_uM | 4.688 | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity [AID540271, Type: confirmatory] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 2 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | AbsAC1000_uM | 4.688 [uM] | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_Dose_CherryPick_Activity | | AID | 540271 | | BioAssay type | confirmatory | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 3 | [SID7972728] | Active | Potency | 5.1735 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT [AID686978, Type: confirmatory] | |  View X | Row No. | 3 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 5.1735 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in absence of CPT | | AID | 686978 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 4 | [SID7972728] | Active | Potency | 6.5131 | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT [AID686979, Type: confirmatory] | |  View X | Row No. | 4 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 6.5131 [uM] | | BioAssay | qHTS for Inhibitors of human tyrosyl-DNA phosphodiesterase 1 (TDP1): qHTS in cells in presence of CPT | | AID | 686979 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 5 | [SID7972728] | Active | Potency | 7.0795 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 5 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 6 | [SID7972728] | Active | Potency | 7.0795 | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) [AID1688, Type: confirmatory] | huntingtin [Homo sapiens] [gi:90903231] |  View X | Row No. | 6 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 7.0795 [uM] | | BioAssay | qHTS Multiplex Assay to Identify Dual Action Probes in a Cell Model of Huntington: Aggregate Formation (GFP) | | AID | 1688 | | BioAssay type | confirmatory | | Target | huntingtin [Homo sapiens] [gi:90903231] | | PubMed | | | Data Table |  |
|
| 7 | [SID7972728] | Active | Potency | 11.2202 | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) [AID651820, Type: confirmatory] | |  View X | Row No. | 7 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 11.2202 [uM] | | BioAssay | qHTS Assay for Inhibitors of Hepatitis C Virus (HCV) | | AID | 651820 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 8 | [SID7972728] | Active | Potency | 12.5893 | qHTS Assay for Anthrax Lethal Toxin Internalization [AID912, Type: confirmatory] | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] |  View X | Row No. | 8 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 12.5893 [uM] | | BioAssay | qHTS Assay for Anthrax Lethal Toxin Internalization | | AID | 912 | | BioAssay type | confirmatory | | Target | lethal factor [Bacillus anthracis str. A2012] [gi:21392848] | | PubMed | | | Data Table |  |
|
| 9 | [SID7972728] | Active | EC50 | 12.72 | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen [AID2253, Type: confirmatory] | |  View X | Row No. | 9 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | EC50 | 12.72 [uM] | | BioAssay | A cytotoxicity screen of small molecule inhibitors of the PhoP regulon in Salmonella typhimurium identified in the primary screen | | AID | 2253 | | BioAssay type | confirmatory | | Target | | | PubMed | | | Data Table |  |
|
| 10 | [SID7972728] | Active | Potency | 56.2341 | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain [AID504339, Type: confirmatory] | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] |  View X | Row No. | 10 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | Potency | 56.2341 [uM] | | BioAssay | qHTS Assay for Inhibitors of JMJD2A-Tudor Domain | | AID | 504339 | | BioAssay type | confirmatory | | Target | Chain A, Jmjd2a Tandem Tudor Domains In Complex With A Trimethylated Histone H4-K20 Peptide [gi:162330054] | | PubMed | | | Data Table |  |
|
| 11 | [SID7972728] | Active | | | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin [AID2314, Type: screening] | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] |  View X | Row No. | 11 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Cycloheximide Counterscreen for Small Molecule Inhibitors of Shiga Toxin | | AID | 2314 | | BioAssay type | screening | | Target | shiga toxin 1 variant A subunit [Escherichia coli O157:H7] [gi:32400299] | | PubMed | | | Data Table |  |
|
| 12 | [SID7972728] | Active | | | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay [AID602449, Type: screening] | |  View X | Row No. | 12 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | uHTS identification of small molecule inhibitors of the mitochondrial permeability transition pore via an absorbance assay | | AID | 602449 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 13 | [SID7972728] | Active | | | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay [AID624504, Type: screening] | |  View X | Row No. | 13 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Single concentration confirmation of uHTS inhibitor hits of the mitochondrial permeability transition pore via a fluorescent based assay | | AID | 624504 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 14 | [SID7972728] | Active | | | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity [AID651610, Type: screening] | |  View X | Row No. | 14 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | HIV entry: Env-mediated Cell Fusion Measured in Cell-Based System Using Plate Reader - 7013-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 651610 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 15 | [SID7972728] | Active | | | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based high throughput assay for antagonists of the parental CHO cell line, in triplicate [AID492965, Type: screening] | |  View X | Row No. | 15 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Fluorescence-based counterscreen for orexin 1 receptor (OX1R) antagonists: cell-based high throughput assay for antagonists of the parental CHO cell line, in triplicate | | AID | 492965 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 16 | [SID7972728] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay [AID504607, Type: screening] | |  View X | Row No. | 16 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Full-Length Luciferase Counterscreen assay | | AID | 504607 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 17 | [SID7972728] | Active | | | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR [AID463, Type: screening] | |  View X | Row No. | 17 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Cell Proliferation & Viability (Cytotoxicity) Primary Assay 60K MLSMR | | AID | 463 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 18 | [SID7972728] | Active | | | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen [AID598, Type: screening] | |  View X | Row No. | 18 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Human H69AR Lung Tumor Cell Growth Inhibition Assay - 86K Screen | | AID | 598 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 19 | [SID7972728] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Pilot Screen [AID823, Type: screening] | |  View X | Row No. | 19 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Human Colon Tumor Cells Lacking Oncogenic Beta Catenin Expression - Pilot Screen | | AID | 823 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 20 | [SID7972728] | Active | | | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Pilot Screen [AID824, Type: screening] | |  View X | Row No. | 20 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | High Throughput Screen to Identify Compounds that Suppress the Growth of Cells with a Deletion of the PTEN Tumor Suppressor - Pilot Screen | | AID | 824 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 21 | [SID7972728] | Active | | | Screening for Modulators of Post-Golgi Transport, Control Strain [AID738, Type: screening] | |  View X | Row No. | 21 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Screening for Modulators of Post-Golgi Transport, Control Strain | | AID | 738 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 22 | [SID7972728] | Active | | | Leishmania major promastigote HTS [AID1063, Type: screening] | |  View X | Row No. | 22 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Leishmania major promastigote HTS | | AID | 1063 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 23 | [SID7972728] | Active | | | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen [AID1362, Type: screening] | |  View X | Row No. | 23 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Chemical Genetic Screen to Identify Inhibitors of Mitochondrial Fusion - Primary Screen | | AID | 1362 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 24 | [SID7972728] | Active | | | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators [AID1814, Type: screening] | |  View X | Row No. | 24 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | MLPCN Alpha-Synuclein 5'UTR - 5'-UTR binding - activators | | AID | 1814 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 25 | [SID7972728] | Active | | | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID525, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 25 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 525 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 26 | [SID7972728] | Active | | | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID525, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 26 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 525 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 27 | [SID7972728] | Active | | | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) [AID525, Type: screening] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 27 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary Cell-based High Throughput Screening assay for inhibitors of the nuclear receptor Steroidogenic Factor 1 (SF-1) | | AID | 525 | | BioAssay type | screening | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 28 | [SID7972728] | Active | | | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set [AID624256, Type: screening] | |  View X | Row No. | 28 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | HTS to identify compounds that promote myeloid differentiation with MLPCN compound set | | AID | 624256 | | BioAssay type | screening | | Target | | | PubMed | | | Data Table |  |
|
| 29 | [SID7972728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 29 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 30 | [SID7972728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) [AID434989, Type: screening] | orexin receptor type 1 [Homo sapiens] [gi:222080095] |  View X | Row No. | 30 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the orexin 1 receptor (OX1R; HCRTR1) | | AID | 434989 | | BioAssay type | screening | | Target | orexin receptor type 1 [Homo sapiens] [gi:222080095] | | PubMed | | | Data Table |  |
|
| 31 | [SID7972728] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 31 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 32 | [SID7972728] | Active | | | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. [AID504668, Type: screening] | Breast cancer type 1 susceptibility protein [gi:728984] |  View X | Row No. | 32 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Single concentration confirmation of inhibitors of Mdm2/MdmX interaction using a Brca1/Bard1 BiLC Counterscreen assay. | | AID | 504668 | | BioAssay type | screening | | Target | Breast cancer type 1 susceptibility protein [gi:728984] | | PubMed | | | Data Table |  |
|
| 33 | [SID7972728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 33 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 34 | [SID7972728] | Active | | | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) [AID588852, Type: screening] | CHRM1 gene product [Homo sapiens] [gi:37622910] |  View X | Row No. | 34 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Fluorescence-based cell-based primary high throughput screening assay to identify antagonists of the human M1 muscarinic receptor (CHRM1) | | AID | 588852 | | BioAssay type | screening | | Target | CHRM1 gene product [Homo sapiens] [gi:37622910] | | PubMed | | | Data Table |  |
|
| 35 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Potentiator Assay 60K MLSMR [AID466, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 35 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Potentiator Assay 60K MLSMR | | AID | 466 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 36 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Potentiator Assay 60K MLSMR [AID466, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 36 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Potentiator Assay 60K MLSMR | | AID | 466 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 37 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Parental Cell Line Counter Screen 60K MLSMR [AID467, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 37 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Parental Cell Line Counter Screen 60K MLSMR | | AID | 467 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 38 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Parental Cell Line Counter Screen 60K MLSMR [AID467, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 38 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Parental Cell Line Counter Screen 60K MLSMR | | AID | 467 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 39 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR [AID468, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 39 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR | | AID | 468 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 40 | [SID7972728] | Active | | | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR [AID468, Type: confirmatory] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 40 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Dose Response Assays for S1P1 Agonists and Agonism Potentiators - Agonist Assay 60K MLSMR | | AID | 468 | | BioAssay type | confirmatory | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 41 | [SID7972728] | Active | | | Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators [AID449, Type: screening] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 41 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators | | AID | 449 | | BioAssay type | screening | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 42 | [SID7972728] | Active | | | Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators [AID449, Type: screening] | S1PR1 gene product [Homo sapiens] [gi:13027636] |  View X | Row No. | 42 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary HTS and Confirmation Assays for S1P1 Agonists and Agonism Potentiators | | AID | 449 | | BioAssay type | screening | | Target | S1PR1 gene product [Homo sapiens] [gi:13027636] | | PubMed | | | Data Table |  |
|
| 43 | [SID7972728] | Active | | | Primary HTS Assay for S1P3 Antagonists [AID485, Type: screening] | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] |  View X | Row No. | 43 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary HTS Assay for S1P3 Antagonists | | AID | 485 | | BioAssay type | screening | | Target | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] | | PubMed | | | Data Table |  |
|
| 44 | [SID7972728] | Active | | | Primary HTS Assay for S1P3 Antagonists [AID485, Type: screening] | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] |  View X | Row No. | 44 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary HTS Assay for S1P3 Antagonists | | AID | 485 | | BioAssay type | screening | | Target | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] | | PubMed | | | Data Table |  |
|
| 45 | [SID7972728] | Active | | | Primary HTS Assay for S1P3 Antagonists [AID485, Type: screening] | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] |  View X | Row No. | 45 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Primary HTS Assay for S1P3 Antagonists | | AID | 485 | | BioAssay type | screening | | Target | sphingosine 1-phosphate receptor 3 [Homo sapiens] [gi:38788193] | | PubMed | | | Data Table |  |
|
| 46 | [SID7972728] | Active | | | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID611, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 46 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 611 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 47 | [SID7972728] | Active | | | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID611, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 47 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 611 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 48 | [SID7972728] | Active | | | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) [AID611, Type: confirmatory] | NR5A1 gene product [Homo sapiens] [gi:20070193] |  View X | Row No. | 48 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Counterscreen for inhibitors of the Retinoic Acid Receptor-related orphan receptor A (RORA): A cell-based dose-response assay for inhibition of the Steroidogenic Factor 1 (SF-1) | | AID | 611 | | BioAssay type | confirmatory | | Target | NR5A1 gene product [Homo sapiens] [gi:20070193] | | PubMed | | | Data Table |  |
|
| 49 | [SID7972728] | Active | | | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity [AID504582, Type: screening] | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] |  View X | Row No. | 49 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | In vivo-based yeast HTS to detect compounds rescuing yeast growth/survival of Plasmodium Falciparum HSP40-mediated toxicity Measured in Whole Organism System Using Plate Reader - 2120-01_Inhibitor_SinglePoint_HTS_Activity | | AID | 504582 | | BioAssay type | screening | | Target | HSP40, subfamily A, putative [Plasmodium falciparum 3D7] [gi:124809271] | | PubMed | | | Data Table |  |
|
| 50 | [SID7972728] | Active | | | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) [AID624379, Type: screening] | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] |  View X | Row No. | 50 | | Structure |
| | Substance | | | SID | 7972728 | | CID | 6860069 | | Outcome | Active | | BioAssay | Counterscreen for agonists of nuclear receptor subfamily 2, group E, member 3 (NR2E3): Luminescence-based cell-based high throughput screening assay to identify agonists of the Herpes Virus Virion Protein 16 (VP16) | | AID | 624379 | | BioAssay type | screening | | Target | transactivating tegument protein VP16 [Human herpesvirus 1] [gi:9629429] | | PubMed | | | Data Table |  |
|